[EN] NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS<br/>[FR] NOUVEAUX DÉRIVÉS DE HYDROXY-6-HÉTÉROARYLPHÉNANTHRIDINE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE PDE4
申请人:ALTANA PHARMA AG
公开号:WO2005085225A1
公开(公告)日:2005-09-15
Compounds of formula (I), in which R1 is hydroxyl, 1-4C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy, 2,2-difluoroethoxy, or completely or predominantly fluorine-substituted 1-4C-alkoxy, R2 is hydroxyl, 1-4C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy, 2,2-difluoroethoxy, or completely or predominantly fluorine-substituted 1-4C-alkoxy, or in which R1 and R2 together are a 1-2C-alkylenedioxy group, R3 is hydrogen or 1-4C-alkyl, R31 is hydrogen or 1-4C-alkyl, either, in a first embodiment (embodiment a) according to the present invention, R4 is -O-R41, in which R41 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy-1-4C-alkyl, hydroxy-2-4C-alkyl, 1-7C-alkylcarbonyl, or completely or predominantly fluorine-substituted 1-4C-alkyl, and R5 is hydrogen or 1-4C-alkyl, or, in a second embodiment (embodiment b) according to the present invention, R4 is hydrogen or 1-4C-alkyl, and R5 is -O-R51, in which R51 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy-1-4C-alkyl, hydroxy-2-4C-alkyl, 1-7C-alkylcarbonyl, or completely or predominantly fluorine-substituted 1-4C-alkyl, Har is optionally substituted by R6 and/or R7 and/or R8, and is a 5- to 10-membered monocylic or fused bicyclic unsaturated or partially saturated heteroaryl radical comprising 1 to 4 heteroatoms selected independently from the group consisting of oxygen, nitrogen and sulfur, are novel effective PDE4 inhibitors.
公式(I)中的化合物,其中R1是羟基,1-4C-烷氧基,3-7C-环氧基,3-7C-环烷基甲氧基,2,2-二氟乙氧基,或完全或主要氟代的1-4C-烷氧基,R2是羟基,1-4C-烷氧基,3-7C-环氧基,3-7C-环烷基甲氧基,2,2-二氟乙氧基,或完全或主要氟代的1-4C-烷氧基,或者R1和R2一起是1-2C-烷二氧基基团,R3是氢或1-4C-烷基,R31是氢或1-4C-烷基,在本发明的第一实施例(实施例a)中,R4是-O-R41,其中R41是氢,1-4C-烷基,1-4C-烷氧基-1-4C-烷基,羟基-2-4C-烷基,1-7C-烷基羰基,或完全或主要氟代的1-4C-烷基,而R5是氢或1-4C-烷基,或者在本发明的第二实施例(实施例b)中,R4是氢或1-4C-烷基,而R5是-O-R51,其中R51是氢,1-4C-烷基,1-4C-烷氧基-1-4C-烷基,羟基-2-4C-烷基,1-7C-烷基羰基,或完全或主要氟代的1-4C-烷基,Har可选地由R6和/或R7和/或R8取代,并且是包含1至4个异原子(独立选择自氧、氮和硫组成的)的5-到10-成员单环或融合的双环不饱和或部分饱和杂环基团,是新颖的有效PDE4抑制剂。